Antidepressants for smoking cessation

Cites (372)

Items 201–375 of 375

1. Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.
   Gary E. Swan, Lisa M. Jack, Ana Maria Valdes, Huijun Z. Ring, Carl C.T. Ton, Susan J. Curry, Tim A. McAfee · 2007 · Health Psychology
2. Bupropion and nicotine patch as smoking cessation aids in alcoholics
   Kathleen M. Grant, Stephanie Sinclair Kelley, Lynette M. Smith, Sangeeta Agrawal, James R. Meyer, Debra J. Romberger · 2007 · Alcohol
3. Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking
   Peter Gariti, Kevin G. Lynch, Arthur I. Alterman, Klye Kampman, Hu Xie, Kristi Varillo · 2009 · Journal of Substance Abuse Treatment
4. Association of CHRNA5-A3-B4 SNP rs2036527 With Smoking Cessation Therapy Response in African-American Smokers
   Andy Z. X. Zhu, Qian Zhou, Lisa Sanderson Cox, Sean P. David, Jasjit S. Ahluwalia, Neal L. Benowitz, Rachel Fynvola Tyndale · 2014 · Clinical Pharmacology & Therapeutics
5. Non-Nicotine Pharmacotherapy for Smoking Cessation
   Neal L. Benowitz, Margaret Wilson Peng · 2000 · CNS Drugs
6. Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity.
   Lirio S. Covey, Maria Botello-Harbaum, Alexander H. Glassman, Jenny R. Masmela, Catherine LoDuca, Victoria Salzman, Fried, Jane · 2008 · PubMed
7. Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion
   E. Paul Wileyto, Freda Patterson, RAYMOND S. NIAURA, Leonard H. Epstein, Richard A. Brown, Janet E. Audrain-McGovern, Larry W. Hawk, Caryn E. Lerman · 2005 · Nicotine & Tobacco Research
8. Influence of fluoxetine on positive and negative affect in a clinic-based smoking cessation trial
   Cook, Jessica Werth, Spring, Bonnie, McChargue, Dennis E., Borrelli, Belinda, Hitsman, Brian, Niaura, Raymond, Keuthen, Nancy J., Kristeller, Jean · 2004 · Psychopharmacology
9. Assessment of nicotine dependence among adolescent and young adult smokers: A comparison of measures
   Matthew J. Carpenter, Nathaniel L. Baker, Kevin Michael Gray, Himanshu P. Upadhyaya · 2010 · Addictive Behaviors
10. Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia
    Elaine Weiner, M. Patricia Ball, Alison S. Buchholz, James M. Gold, Anne Eden Evins, Robert P. McMahon, Robert W. Buchanan · 2011 · The Journal of Clinical Psychiatry
11. Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
    Paul M. Cinciripini, Janice Y. Tsoh, David W. Wetter, Cho Y. Lam, Carl de Moor, Lynn G. Cinciripini, Walter F. Baile, Cheryl B. Anderson, John Dorrance Minna · 2005 · Experimental and Clinical Psychopharmacology
12. Bupropion and cognitive-behavioral therapy for smoking cessation in women
    Joy M. Schmitz, Angela L. Stotts, Marc E. Mooney, Katherine A. DeLaune, Gerard F. Moeller · 2007 · Nicotine & Tobacco Research
13. Cost-effectiveness of an Intensive Smoking Cessation Intervention for COPD Outpatients
    Lieke C.A. Christenhusz, Rilana Prenger, Marcel E. Pieterse, Erwin R. Seydel, Job A.M. van der Palen · 2011 · Nicotine & Tobacco Research
14. Buspirone Reduces Smoking
    Frank H. Gawin · 1989 · Archives of General Psychiatry
15. Smoking Cessation After Acute Myocardial Infarction
    Neal L. Benowitz, Judith J. Prochaska · 2013 · Journal of the American College of Cardiology
16. An Employer-Based Cost-Benefit Analysis of a Novel Pharmacotherapy Agent for Smoking Cessation
    Kenneth C. Jackson, Robert Nahoopii, Qayyim Said, Riad D Dirani, Diana I Brixner · 2007 · Journal of Occupational and Environmental Medicine
17. General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: Impact after 1year of two complex interventions
    Sander R. Hilberink, J. Jacobs, MARINUS H. M. BRETELER, Hein de Vries, Richard P.T.M. Grol · 2010 · Patient Education and Counseling
18. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study
    Lowell C. Dale, Jon O. Ebbert, Darrell R. Schroeder, Ivana T. Croghan, Donna F. Rasmussen, Judith A. Trautman, Lisa Sanderson Cox, R. Douglas Hurt · 2002 · Nicotine & Tobacco Research
19. Bupropion May Support Psychosocial Treatment of Nicotine‐Dependent Adolescents: Preliminary Results
    Helmut Niederhofer, Markus Karl Huber · 2004 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
20. Bupropion SR for the treatment of smokeless tobacco use
    Lowell C. Dale, Jon O. Ebbert, Elbert D. Glover, Ivana T. Croghan, Darrell R. Schroeder, Herbert H. Severson, R. Douglas Hurt · 2007 · Drug and Alcohol Dependence
21. Changes in health-related quality of life with smoking cessation treatment
    James Taylor Hays, Ivana T. Croghan, Christine L. Baker, Joseph C. Cappelleri, Andrew G. Bushmakin · 2010 · European Journal of Public Health
22. Naturalistic, Self‐Assignment Comparative Trial of Bupropion SR, a Nicotine Patch, or Both for Smoking Cessation Treatment in Primary Care
    Paul B. Gold, Robert N. Rubey, Richard T. Harvey · 2002 · American Journal on Addictions
23. Effect of Cessation Interventions on Hookah Smoking: Post-Hoc Analysis of a Cluster-Randomized Controlled Trial
    Omara F. Dogar, Mohammed Jawad, Sarwat Shah, James Nicholas Newell, Mona N Kanaan, Muhammad Amjad Khan, Kamran Siddiqi · 2013 · Nicotine & Tobacco Research
24. Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice
    Nikoletta Rovina, Ioanna Nikoloutsou, Georgia Katsani, Efrossini Dima, Konstantinos Fransis, Charis Roussos, Christina Gratziou · 2009 · Therapeutic Advances in Respiratory Disease
25. A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers☆
    Andrea H. Weinberger, Erin L. Reutenauer, Peter I. Jatlow, Stephanie S. O’Malley, Marc Nicholas Potenza, Tony Peter George · 2009 · Drug and Alcohol Dependence
26. A randomized controlled trial of a smoking cessation intervention conducted among prisoners
    ROBYN L. RICHMOND, Devon Indig, Tony Gerard Butler, Kay A Wilhelm, Vicki Archer, ALEX D. WODAK · 2012 · Addiction
27. Do Serotonin Uptake Inhibitors Decrease Smoking? Observations in a Group of Heavy Drinkers
    Edward M. Sellers, Claudio A. Naranjo, Karen E. Kadlec · 1987 · Journal of Clinical Psychopharmacology
28. A randomized trial of short psychotherapy versus sustained‐release bupropion for smoking cessation
    Gerald Zernig, Reinhild Wallner, Ursula Grohs, Norbert Kriechbaum, Georg Kemmler, Alois Saria · 2008 · Addiction
29. A Comparison of Sustained-release Bupropion and Placebo for Smokeless Tobacco Cessation
    Elbert D. Glover, Penny N. Glover, Carl R. Sullivan, Connie L Cerullo, Gerald R. Hobbs · 2002 · American Journal of Health Behavior
30. Weight suppression and weight rebound in ex-smokers treated with fluoxetine.
    Belinda Borrelli, Bonnie J. Spring, RAYMOND S. NIAURA, Jean L. Kristeller, Judith K. Ockene, Nancy J. Keuthen · 1999 · Journal of Consulting and Clinical Psychology
31. A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia
    S. Hossein Fatemi, Joel M. Stary, Dorothy K. Hatsukami, Sharon E. Murphy · 2005 · Schizophrenia Research
32. Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial
    Daniel Kotz, Geertjan Wesseling, Marcus J. H. Huibers, Onno C. P. van Schayck · 2007 · BMC Public Health
33. No Evidence for a Major Role of Polymorphisms During Bupropion Treatment
    Jianfang Hu, David T. Redden, Wade H. Berrettini, Peter G. Shields, Stephanie L. Restine, Angela G. Pinto, Caryn E. Lerman, David B. Allison · 2006 · Obesity
34. Fluoxetine, smoking, and history of major depression: A randomized controlled trial.
    Bonnie J. Spring, Neal Doran, Sherry Pagoto, Dennis E. McChargue, Jessica Werth Cook, Katherine C. Bailey, John W. Crayton, Donald Hedeker · 2007 · Journal of Consulting and Clinical Psychology
35. Preliminary Study of Buprenorphine and Bupropion for Opioid‐Dependent Smokers
    Marc E. Mooney, James C. Poling, Gerardo M. Gonzalez, Kishor Gonsai, Thomas R. Kosten, Mehmet Sofuoglu · 2008 · American Journal on Addictions
36. Bupropion SR vs Placebo for Smoking Cessation in Health Care Professionals
    Jean-Pierre Zellweger, Pal L. Boelcskei, Laura Carrozzi, Ruth Sepper, R. Sweet, A. Hider · 2005 · American Journal of Health Behavior
37. Effects of doxepin on withdrawal symptoms in smoking cessation
    Joseph K. Murphy, Neil B. Edwards, A D Downs, B J Ackerman, T L Rosenthal · 1990 · American Journal of Psychiatry
38. A Double-blind, Placebo-Controlled, Randomized Trial of Bupropion for Smoking Cessation in Primary Care
    Roldano Fossati · 2007 · Archives of Internal Medicine
39. Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation
    Adam Matthew Leventhal, Sean P. David, Molly Brightman, David R. Strong, John E. McGeary, Richard A. Brown, Elizabeth E. Lloyd‐Richardson, Marcus Robert Munafo, George R. Uhl, RAYMOND S. NIAURA · 2010 · The Pharmacogenomics Journal
40. Smoking cessation in primary care – a randomized controlled trial of bupropione, nicotine replacements, <scp>CBT</scp> and a minimal intervention
    Wittchen, Hans‐Ulrich, Hoch, Eva, Klotsche, Jens, Muehlig, Stephan · 2011 · International Journal of Methods in Psychiatric Research
41. Do small lapses predict relapse to smoking behavior under bupropion treatment?
    Paul Wileyto, Freda Patterson, RAYMOND S. NIAURA, Leonard H. Epstein, Richard A. Brown, Janet E. Audrain-McGovern, Larry W. Hawk, Caryn E. Lerman, Freda Patterson · 2004 · Nicotine & Tobacco Research
42. A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis
    Mahshid Aryanpur, Mostafa Hosseini, Mohammad Reza Masjedi, Esmaeil Mortaz, Payam Tabarsi, Hamid Soori, Habib Emami, Gholamreza Heidari, Mehdi Kazempour Dizagie, Masoud Baikpour · 2016 · BMC Infectious Diseases
43. Double-blind fluoxetine in depressed alcoholic smokers.
    Jack R. Cornelius, Ihsan M. Salloum, Joan G. Ehler, Patricia J. Jarrett, Marie D. Cornelius, Ann Black, James M. Perel, Michael E. Thase · 1997 · PubMed
44. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion
    Sean P. David, David R. Strong, Adam Matthew Leventhal, Molly Lancaster, John E. McGeary, Marcus Robert Munafo, Andrew W. Bergen, Gary E. Swan, Neal L. Benowitz, Rachel Fynvola Tyndale et al. · 2013 · Addiction
45. Effects of fluoxetine on weight gain and food intake in smokers who reduce nicotine intake
    Ovide F. Pomerleau, Cynthia S. Pomerleau, Eric M. Morrell, John M. Lowenbergh · 1991 · Psychoneuroendocrinology
46. Subjective sleep disturbance during a smoking cessation program: Associations with relapse
    Michele L. Okun, Michele D. Levine, Patricia R. Houck, Kenneth A. Perkins, Marsha D. Marcus · 2011 · Addictive Behaviors
47. Paths to tobacco abstinence: A repeated-measures latent class analysis.
    Danielle E. McCarthy, Lemma Ebssa, Katie A. Witkiewitz, Saul S. Shiffman · 2015 · Journal of Consulting and Clinical Psychology
48. Impact of Prior Nicotine Replacement Therapy on Smoking Cessation Efficacy
    Michael J. Durcan, Jonathan D. White, Joseph A. Johnston, Mitchell A. Nides, Douglas E. Jorenby, Michael C. Fiore, Scott James Leischow, John A. Ascher, Stephen I. Rennard · 2002 · American Journal of Health Behavior
49. A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year
    Grassi, M. Caterina, Enea, Domenico, Ferketich, Amy K., Lu, Bo, Nencini, Paolo · 2009 · Nicotine &amp; Tobacco Research
50. Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States
    Ivana T. Croghan, R. Douglas Hurt, Jon O. Ebbert, Gary A. Croghan, Octavius D. Polk, Philip J. Stella, Paul J. Novotny, Jeff A. Sloan, Charles L. Loprinzi · 2009 · Journal of Public Health
51. Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers
    Ivan Berlin, Odile Spreux‐Varoquaux, Sophie Saïd, Jean‐Marie Launay · 1997 · Drug and Alcohol Dependence
52. Treatment for Tobacco Dependence: Effect on Brain Nicotinic Acetylcholine Receptor Density
    Arthur L. Brody, Alexey G. Mukhin, Stephanie Shulenberger, Michael S Mamoun, Maggie Kozman, Jonathan Phuong, Meaghan K. Neary, Trinh Luu, Mark A. Mandelkern · 2013 · Neuropsychopharmacology
53. Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program
    Robert A. Schnoll, Elisa Martinez, Corey Jay Langer, Curtis T. Miyamoto, Frank T. Leone · 2011 · Acta Oncologica
54. Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm
    Jed E. Rose, Frédérique M. Behm · 2016 · Nicotine & Tobacco Research
55. Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy
    Joel D. Killen, Stephen P. Fortmann, Greer M. Murphy, Chris Hayward, Dalea Fong, Kimberly Lowenthal, Susan W. Bryson, Diana T. Killen, Alan F. Schatzberg · 2010 · Addiction
56. Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: A double-blind placebo and bupropion-controlled study
    S. Hossein Fatemi, Mahtab Karkhane Yousefi, Rachel E. Kneeland, Stephanie B. Liesch, Timothy D. Folsom, PAUL D. THURAS · 2013 · Schizophrenia Research
57. Experimenter‐defined quit dates for smoking cessation: adherence improves outcomes for women but not for men
    Belinda Borrelli, George D. Papandonatos, Bonnie J. Spring, Brian L. Hitsman, RAYMOND S. NIAURA · 2004 · Addiction
58. Effect of Nonnicotine Pharmacotherapy on Smoking Behavior
    Kotlyar, Michael, Golding, Michael, Hatsukami, Dorothy K., Jamerson, Brenda D. · 2001 · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
59. Should All Smokers Use Combination Smoking Cessation Pharmacotherapy? Using Novel Analytic Methods to Detect Differential Treatment Effects Over 8 Weeks of Pharmacotherapy
    Wei‐Yin Loh, Megan E. Piper, Tanya R. Schlam, M. C. Fiore, Stevens S. Smith, Douglas E. Jorenby, J. W. Cook, Daniel M. Bolt, T. B. Baker · 2011 · Nicotine & Tobacco Research
60. Elevated positive mood: A mixed blessing for abstinence.
    Neal Doran, Bonnie J. Spring, Belinda Borrelli, Dennis E. McChargue, Brian L. Hitsman, RAYMOND S. NIAURA, Donald Hedeker · 2006 · Psychology of Addictive Behaviors
61. Bupropion SR and smoking cessation in actual practice: methods for recruitment, screening, and exclusion for a field trial in a managed-care setting☆☆Research supported by Grant CA71358 from the National Cancer Institute to SRI International. Bupropion SR provided by Group Health Cooperative Pharmacy.
    Lisa M. Jack, Gary E. Swan, Ella Thompson, Susan J. Curry, Tim A. McAfee, Sara Dacey, Katherine Bergman · 2003 · Preventive Medicine
62. Pharmacogenetic Association of the Galanin Receptor (GALR1) SNP rs2717162 with Smoking Cessation
    Allison B. Gold, E. Paul Wileyto, Adriana Lori, David V. Conti, Joseph F. Cubells, Caryn E. Lerman · 2012 · Neuropsychopharmacology
63. An Evaluation of the Italian Version of the Fagerström Test for Nicotine Dependence
    Fekketich, Amy K., Fossati, Roldano, Apolone, Giovanni · 2008 · Psychological Reports
64. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: Results from a randomized, double-blind, placebo-controlled study
    David Kalman, Lawrence R. Herz, Peter M. Monti, Christopher W. Kahler, Marc E. Mooney, Stephanie Rodrigues, Kathryn O’Connor · 2011 · Drug and Alcohol Dependence
65. Utilization of evidence-based therapy for acute coronary syndrome in high-income and low/middle-income countries.
    A. Shimony, S. Grandi, L. Pilote, L. Joseph, J. O'Loughlin, G. Paradis, S. Rinfret, N. Sarrafzadegan, N. Adamjee, R. Yadav et al. · 2014 · American Journal of Cardiology
66. A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics
    James Taylor Hays, R. Douglas Hurt, Paul A. Decker, Ivana T. Croghan, Kenneth P. Offord, Christi A. Patten · 2009 · Nicotine & Tobacco Research
67. Efficacy of Sequential Use of Fluoxetine for Smoking Cessation in Elevated Depressive Symptom Smokers
    Richard A. Brown, Ana M. Abrantes, David R. Strong, RAYMOND S. NIAURA, Christopher W. Kahler, Ivan W. Miller, Lawrence H. Price · 2013 · Nicotine & Tobacco Research
68. A Randomized Clinical Trial of St. John's Wort for Smoking Cessation
    Amit Sood, Jon O. Ebbert, Kavita Prasad, Ivana T. Croghan, Brent A. Bauer, Darrell R. Schroeder · 2010 · The Journal of Alternative and Complementary Medicine
69. Regular Exercise as a Protective Factor in Relapse following Smoking Cessation Treatment
    Ana M. Abrantes, David R. Strong, Elizabeth E. Lloyd‐Richardson, RAYMOND S. NIAURA, Christopher W. Kahler, Richard A. Brown · 2009 · American Journal on Addictions
70. Measuring nicotine dependence among smokeless tobacco users
    Janet Thomas, Jon O. Ebbert, Christi A. Patten, Lowell C. Dale, Carrie A. Bronars, Darrell R. Schroeder · 2006 · Addictive Behaviors
71. Bupropion and naltrexone for smoking cessation: A double‐blind randomized placebo‐controlled clinical trial
    ME Mooney, Joy M. Schmitz, SHARON S. ALLEN, John G. Grabowski, Paul R. Pentel, A Oliver, DK Hatsukami · 2016 · Clinical Pharmacology & Therapeutics
72. A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
    Ali Ramazan Benli, Selman Erturhan, Muhammet Ali Oruç, Pinar Kalpakci, Didem Sunay, Yeltekin Demirel · 2017 · Tobacco Induced Diseases
73. Weight suppression and weight rebound in ex-smokers treated with fluoxetine.
    Belinda Borrelli, Bonnie J. Spring, RAYMOND S. NIAURA · 1999 · Journal of Consulting and Clinical Psychology
74. Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation
    Ivan Berlin, Lirio S. Covey, Huiping Jiang, Dean H. Hamer · 2005 · Nicotine & Tobacco Research
75. An Algorithm Approach to Determining Smoking Cessation Treatment for Persons Living With HIV/AIDS
    Karen L. Cropsey, Bianca F. Jardin, Greer Burkholder, Charles Brendan Clark, James Luther Raper, Michael S. Saag · 2015 · JAIDS Journal of Acquired Immune Deficiency Syndromes
76. Fluoxetine Versus Placebo to Decrease the Smoking of Depressed Alcoholic Patients
    Jack R. Cornelius, Kenneth A. Perkins, Ihsan M. Salloum, Michael E. Thase, Howard B. Moss · 1999 · Journal of Clinical Psychopharmacology
77. Controlled Trial for Smoking Cessation in a Navy Shipboard Population Using Nicotine Patch, Sustained-Release Buproprion, or Both
    Nancy A. Swanson, Charles C. Burroughs, Mark A.D. Long, Robert W. Lee · 2003 · Military Medicine
78. Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation
    Marieke Quaak, Onno C. P. van Schayck, Dirkje Sjoukje Postma, Edwin J. Wagena, Frederik‐Jan van Schooten · 2011 · Addiction
79. An intervention to stop smoking among patients suspected of TB - evaluation of an integrated approach
    Kamran Siddiqi, Amir Zada Khan, Maqsood Ahmad, Shafiq‐ur‐Rehman · 2010 · BMC Public Health
80. Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia
    Boaz Bloch, Alon Reshef, Tamara R. Cohen, Amos Tafla, S. Gathas, Salomon Israel, Inga Gritsenko, Ilana Kremer, Richard P. Ebstein · 2009 · Psychiatry Research
81. Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation
    Robert A. Schnoll, Leonard H. Epstein, Janet E. Audrain, RAYMOND S. NIAURA, Larry W. Hawk, Peter G. Shields, Caryn E. Lerman, E. Paul Wileyto · 2007 · Journal of Substance Abuse Treatment
82. An RCT with the combination of varenicline and bupropion for smoking cessation: clinical implications for front line use
    Paul M. Cinciripini, Jennifer A. Minnix, Charles E. Green, Jason D. Robinson, Jeffrey M. Engelmann, Francesco Versace, David W. Wetter, Sanjay S. Shete, Maher Karam‐Hage · 2018 · Addiction
83. A Pilot Randomised, Open, Uncontrolled, Clinical Study of Two Dosages of St John’s Wort (Hypericum perforatum) Herb Extract (LI-160) as an Aid to Motivational/Behavioural Support in Smoking Cessation
    Joanne Barnes, Nick Barber, David Wheatley, Elizabeth M. Williamson · 2006 · Planta Medica
84. A randomized, open‐label pilot comparison of gabapentin and bupropion SR for smoking cessation
    William D. White, David Neil Crockford, Scott Burton Patten, Nady el‐Guebaly · 2005 · Nicotine & Tobacco Research
85. Sustained-release bupropion for hospital-based smoking cessation: A randomized trial
    Joel A. Simon, Carol L. Duncan, Joy Huggins, Sharon N. Solkowitz, Timothy P. Carmody · 2009 · Nicotine & Tobacco Research
86. Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment
    Paul M. Cinciripini, Charles E. Green, Jason D. Robinson, Maher Karam‐Hage, Jeffrey M. Engelmann, Jennifer A. Minnix, David W. Wetter, Francesco Versace · 2017 · Psychopharmacology
87. Meta-Analysis of Suicidality in Placebo-Controlled Clinical Trials of Adults Taking Bupropion
    Wightman, Donna S., Foster, Vicki J., Krishen, Alok, Richard, Nathalie E., Modell, Jack G. · 2010 · The Primary Care Companion to The Journal of Clinical Psychiatry
88. A randomized trial of smoking cessation. Medication versus motivation
    Meral Uyar, Ayten Filiz, Nazan Gulhan Bayram, Osman Elbek, Hasan Herken, Ayfer Topçu, Öner Dikensoy, Erhan Ekinci · 2007 · Saudi Medical Journal
89. Gender-stratified gene and gene–treatment interactions in smoking cessation
    W Lee, Andrew W. Bergen, Gary E. Swan, Dahai Li, Jingyu Liu, Paul D. Thomas, Rachel Fynvola Tyndale, Neal L. Benowitz, Caryn Lerman, David V. Conti · 2011 · The Pharmacogenomics Journal
90. A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation
    Amanda C Parsons, Jackie T Ingram, Jennie Inglis, Paul N Aveyard, Elaine C Johnstone, Karen S Brown, Mike Franklin, Isabel Bermúdez · 2009 · Drug and Alcohol Dependence
91. Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data
    Lisa Sanderson Cox, Babalola Faseru, Matthew S. Mayo, Ron Krebill, Tricia M. Snow, Carrie A. Bronars, Nicole L. Nollen, Won S. Choi, Kolawole Stephen Okuyemi, Gary A. Salzman et al. · 2011 · Trials
92. Adolescent Smoking Cessation With Bupropion: The Role of Adherence: Table 1.
    Scott James Leischow, Myra L Muramoto, Eva Matthews, Lysbeth L. Floden, Rachel A. Grana · 2015 · Nicotine & Tobacco Research
93. Predictors of Relapse in a Bupropion Trial for Smoking Cessation in Recently-Abstinent Alcoholics: Preliminary Results Using an Aggregate Genetic Risk Score
    John E. McGeary, Valerie S. Knopik, John E. Hayes, Rohan H. C. Palmer, Peter M. Monti, David Kalman · 2012 · Substance Abuse Research and Treatment
94. Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine.
    Brian L. Hitsman, Bonnie J. Spring, Belinda Borrelli, RAYMOND S. NIAURA, George D. Papandonatos · 2001 · Experimental and Clinical Psychopharmacology
95. A Phase II study of St. John's Wort for smoking cessation
    Silvana Lawvere, Martin Christopher Mahoney, K. Michael Cummings, James L. Kepner, Andrew J. Hyland, David D. Lawrence, Jill M. Murphy · 2006 · Complementary Therapies in Medicine
96. Outcomes of Bupropion Therapy for Smoking Cessation During Routine Clinical Use
    Elan Paluck, James P. McCormack, Mary H. H. Ensom, Marc Levine, Judith A. Soon, David W Fielding · 2006 · Annals of Pharmacotherapy
97. Selegiline Transdermal System (STS) as an Aid for Smoking Cessation
    Roberta Kahn, Liza Gorgon, Karen M. Jones, Frances McSherry, Elbert D. Glover, Robert M. Anthenelli, T. Jackson, Jill M. Williams, Cristin Murtaugh, Iván D. Montoya et al. · 2011 · Nicotine & Tobacco Research
98. Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial
    Robert M. Anthenelli, Michael Gaffney, Neal L. Benowitz, Robert West, Thomas D. McRae, Cristina Russ, David Lawrence, Lisa St Aubin, Alok Krishen, Anne Eden Evins · 2019 · Journal of General Internal Medicine
99. Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation
    Raj Kumar, Pranav Pratap Singh · 2010 · Lung India
100. The cost‐effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients
     Onno C. P. van Schayck, J Kaper, Edwin J. Wagena, Emiel F.�M. Wouters, Johannes L. Severens · 2009 · Addiction
101. Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications
     Kenneth A. Perkins, Caryn E. Lerman, Joshua L. Karelitz, Nancy C. Jao, K. N. Roy Chengappa, Garrett M. Sparks · 2013 · Addiction
102. A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch
     Ivan Berlin, Ian M. Hunneyball, Doris Greiling, Stephen P. Jones, HERMANN FUDER, Hans-Detlev Stahl · 2012 · Psychopharmacology
103. A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
     Christine L. Baker, Guilhem Pietri · 2018 · ClinicoEconomics and Outcomes Research
104. Dietary intake after smoking cessation among weight-concerned women smokers.
     Michele D. Levine, Yu Cheng, Melissa Ann Kalarchian, Kenneth A. Perkins, Marsha D. Marcus · 2012 · Psychology of Addictive Behaviors
105. Major depression among adolescent smokers undergoing treatment for nicotine dependence
     Killen, Joel D., Robinson, Thomas N., Ammerman, Seth, Hayward, Chris, Rogers, Jayna, Samuels, Deanne, Schatzberg, Alan F. · 2004 · Addictive Behaviors
106. Modeling smoking cessation data with alternating states and a cure fraction using frailty models
     Yimei Li, E. Paul Wileyto, Daniel F. Heitjan · 2010 · Statistics in Medicine
107. The Impact of Perceived Treatment Assignment on Smoking Cessation Outcomes Among African-American Smokers
     Janet Thomas, Hongfei Guo, Ian M. Lynam, Joshua N. Powell, Kolawole Stephen Okuyemi, Carrie A. Bronars, Jasjit S. Ahluwalia · 2008 · Journal of General Internal Medicine
108. Does Extended Pre Quit Bupropion Aid in Extinguishing Smoking Behavior?
     Larry W. Hawk, Rebecca L. Ashare, Jessica D. Rhodes, Jason A. Oliver, K. Michael Cummings, Martin Christopher Mahoney · 2015 · Nicotine & Tobacco Research
109. The DRD4 Exon III VNTR, Bupropion, and Associations With Prospective Abstinence
     Andrew W. Bergen, Harold S. Javitz, Li Su, Yungang He, David V. Conti, Neal L. Benowitz, Rachel Fynvola Tyndale, Caryn E. Lerman, Gary E. Swan · 2012 · Nicotine & Tobacco Research
110. Evaluating the effect of smoking cessation treatment on a complex dynamical system
     Korkut Bekiroglu, Michael A. Russell, Constantino M. Lagoa, Stephanie T. Lanza, Megan E. Piper · 2017 · Drug and Alcohol Dependence
111. Therapeutic Drug Monitoring of Nortriptyline in Smoking Cessation: A Multistudy Analysis
     ME Mooney, Victor I. Reus, J Gorecki, SM Hall, Gary L. Humfleet, RF Muñoz, Kevin Delucchi · 2007 · Clinical Pharmacology & Therapeutics
112. The impact of chronic bupropion on plasma cotinine and on the subjective effects of ad lib smoking: A randomized controlled trial in unmotivated smokers
     Sarwar Hussain, Laurie A. Zawertailo, Usoa E. Busto, Martin H. Zack, Peter Farvolden, Peter L. Selby · 2009 · Addictive Behaviors
113. Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region
     Jane E. Sarginson, Joel D. Killen, Laura C. Lazzeroni, Stephen P. Fortmann, Heather S. Ryan, Niloufar Ameli, Alan F. Schatzberg, Greer M. Murphy · 2015 · Nicotine & Tobacco Research
114. Buspirone effect on tobacco withdrawal symptoms: a pilot study.
     M D Robinson, W A Smith, Eric A. Cederstrom, Donald E. Sutherland · 1991 · PubMed
115. Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine.
     Brian L. Hitsman, Bonnie J. Spring, Belinda Borrelli · 2001 · Experimental and Clinical Psychopharmacology
116. Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation
     Andrea H. Weinberger, Sherry A. McKee, Tony Peter George · 2010 · Nicotine & Tobacco Research
117. Bupropion SR for Relapse Prevention: A “Slips-Allowed“ Analysis
     Micahel Durcan · 2004 · American Journal of Health Behavior
118. Factors Associated with Discontinuation of Bupropion and Counseling Among African American Light Smokers in a Randomized Clinical Trial
     Nicole L. Nollen, Matthew S. Mayo, Jasjit S. Ahluwalia, Rachel Fynvola Tyndale, Neal L. Benowitz, Babalola Faseru, Taneisha S. Scheuermann, Lisa Sanderson Cox · 2013 · Annals of Behavioral Medicine
119. Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals
     Theresa M. Winhusen, Maxine L. Stitzer, GEORGE E. WOODY, Gregory S. Brigham, Frankie Banta Kropp, Udi E. Ghitza, Robert Lindblad, Bryon H. Adinoff, Cindy L. Green, Gaurav Sharma et al. · 2011 · Contemporary Clinical Trials
120. The efficacy of the combination of sertraline with buspirone for smoking cessation
     Jorge Luiz Carrão, Leila Beltrami Moreira, Flávio Danni Fuchs · 2007 · European Archives of Psychiatry and Clinical Neuroscience
121. Factors associated with smoking menthol cigarettes among treatment-seeking African American light smokers
     Babalola Faseru, Won S. Choi, Ron Krebill, Matthew S. Mayo, Nicole L. Nollen, Kolawole Stephen Okuyemi, Jasjit S. Ahluwalia, Lisa Sanderson Cox · 2011 · Addictive Behaviors
122. Assessment of Depression among African American Light Smokers
     Carla J. Berg, Lisa Sanderson Cox, Won S. Choi, Matthew S. Mayo, Ron Krebill, Carrie A. Bronars, Jasjit S. Ahluwalia · 2011 · Journal of Health Psychology
123. Intention to quit moderates the effect of bupropion on smoking urge
     Jennifer W. Tidey, Damaris J. Rohsenow · 2009 · Nicotine & Tobacco Research
124. A man before his time: Russell's insights into nicotine, smoking, treatment and curbing the smoking problem
     Ann D. McNeill, Debbie Robson · 2017 · Addiction
125. Smoking abstinence symptoms across 67 days compared with randomized controls—Moderation by nicotine replacement therapy, bupropion, and negative-affect traits.
     David G. Gilbert, Norka E. Rabinovich, Elizabeth A Gilbert-Matuskowitz, Keith P. Klein, Michele L. Pergadia · 2019 · Experimental and Clinical Psychopharmacology
126. Depressive Symptoms Among Patients Receiving Varenicline and Bupropion for Smoking Cessation
     Arthur S. Hong, Muhamad Y. Elrashidi, D. Schroeder, J. Ebbert · 2014 · Journal of Substance Abuse Treatment
127. The dynamics of the urge‐to‐smoke following smoking cessation via pharmacotherapy
     Harold S. Javitz, Gary E. Swan, Caryn E. Lerman · 2011 · Addiction
128. Cessation treatment adherence and smoking abstinence in patients after acute myocardial infarction
     Sonia Marzia Grandi, Mark Jeffrey Eisenberg, Lawrence Joseph, Jennifer L O’Loughlin, Gilles Paradis, Kristian B. Filion · 2015 · American Heart Journal
129. Sustained-Release Bupropion for Smoking Cessation in a Chinese Sample: A Double-Blind, Placebo-Controlled, Randomized Trial
     Lihan Sheng, Y.-l. Tang, Zuo-Ning Jiang, C.-h. Yao, J.-y. Gao, G.Z. Xu, X.-y. Tong · 2012 · Nicotine & Tobacco Research
130. Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential
     Francesco Versace, Elise M. Stevens, Jason D. Robinson, Yong Cui, Menton M. Deweese, Jeffrey M. Engelmann, Charles E. Green, Maher Karam‐Hage, Cho Y. Lam, Jennifer A. Minnix et al. · 2017 · Nicotine & Tobacco Research
131. S -Adenosyl- l -Methionine (SAMe) for Smoking Abstinence: A Randomized Clinical Trial
     Amit Sood, Kavita Prasad, Ivana T. Croghan, Darrell R. Schroeder, Shawna L. Ehlers, Jon O. Ebbert · 2012 · The Journal of Alternative and Complementary Medicine
132. Bupropion-SR for Smoking Cessation in Early Recovery from Alcohol Dependence: A Placebo-Controlled, Double-Blind Pilot Study
     Maher Karam‐Hage, Stephen Strobbe, Jason D. Robinson, Kirk J. Brower · 2011 · The American Journal of Drug and Alcohol Abuse
133. [Effect of treatment for nicotine dependence in patients with COPD].
     Dorota Górecka, Michał Bednarek, Adam Nowiński, Elżbieta Puścińska, Anna Goljan-Geremek, Jan Zielinski · 2003 · PubMed
134. Pragmatic, observational study of bupropion treatment for smoking cessation in general practice
     Scott Wilkes, A Evans, Mark A Henderson, J Gibson · 2005 · Postgraduate Medical Journal
135. Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial
     Laurie A. Zawertailo, Tara Mansoursadeghi-Gilan, Helena Zhang, Sarwar Hussain, Bernard Le Foll, Peter L. Selby · 2018 · JMIR Research Protocols
136. BMI changes in adolescents treated with bupropion SR for smoking cessation
     Lysbeth L. Floden, DOUGLAS L. TAREN, Myra L Muramoto, Scott James Leischow · 2015 · Obesity
137. Bupropion SR for smoking cessation in pregnancy: a pilot study
     Hugh S Miller, James Ranger‐Moore, Marla Hingtgen · 2003 · American Journal of Obstetrics and Gynecology
138. Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men
     Melodie Isgro, Neal Doran, Jaimee L. Heffner, Esther Wong, Elizabeth Dinh, Jessie J. Tibbs, Katie Russell, Tracy Bittner, Chris Wehrle, Matthew J. Worley et al. · 2017 · Journal of Studies on Alcohol and Drugs
139. Comparison of the Effectiveness of Varenicline, Extended-Release Bupropion and Nicotine Replacement Therapy on The Success and the Maintenance of a Smoking Cessation Program
     Selma Bozkurt Zincir, Serkan Zincir, Esra Kaymak, Esra Aydın Sünbül · 2013 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
140. Bupropion, smoking cessation, and health-related quality of life following an acute myocardial infarction.
     David Dong Qi Zhang, Mark Jeffrey Eisenberg, Sonia Marzia Grandi, Lawrence Joseph, Jennifer L O’Loughlin, Gilles Paradis, Pedro Lozano, Kristian B. Filion · 2014 · PubMed
141. Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline
     Sharon Hall, Julie A. Gorecki, Victor I. Reus, Gary L. Humfleet, Ricardo F. Muñoz · 2007 · Nicotine & Tobacco Research
142. Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: A growth curve modeling approach.
     Haruka Minami, Christopher W. Kahler, Erika Litvin Bloom, Mark A. Prince, Ana M. Abrantes, David R. Strong, RAYMOND S. NIAURA, Ivan W. Miller, Kathleen M. Palm Reed, Lawrence H. Price et al. · 2014 · Experimental and Clinical Psychopharmacology
143. Weight Change in Patients Attempting to Quit Smoking Post-myocardial Infarction
     Sonia Marzia Grandi, Kristian B. Filion, André Gervais, Lawrence Joseph, Jennifer L O’Loughlin, Gilles Paradis, Stéphane Rinfret, Louise Pilote, François R. Grondin, Sohrab R. Lutchmedial et al. · 2014 · The American Journal of Medicine
144. Nicotine reduction: Effectiveness of bupropion
     Joseph K. Neumann, Benjamin Peeples, J. East, A. R. Ellis · 2000 · The British Journal of Psychiatry
145. The “Bupropion for Smoking Cessation” Trial From a Family Practice Perspective
     Brian J. Caplan · 2005 · Archives of Internal Medicine
146. Using ecological measures of smoking trigger exposure to predict smoking cessation milestones.
     Haruka Minami, Lisa T. Tran, Danielle E. McCarthy · 2014 · Psychology of Addictive Behaviors
147. Wyniki leczenia uzależnienia od nikotyny chorych na przewlekłą obturacyjną chorobę płuc
     Dorota Górecka, Michał Bednarek, Adam Nowiński, Elżbieta Puścińska, Anna Goljan-Giermek, Jan Zielinski · 2008 · Pneumonologia i Alergologia Polska
148. P.6.f.002 Hypericum perforatum, nicotine patches and combination hypericum perforatum/nicotine patches for smoking cessation
     Marni Kras, Con K. K. Stough, Andrew B Scholey, Christina Kure, David Camfield · 2010 · European Neuropsychopharmacology
149. Bupropion, Smoking Cessation, and Health-Related Quality of Life Following an Acute Myocardial Infarction
     Ding-Shan Zhang, Mark Jeffrey Eisenberg, Sonia Marzia Grandi, L. Joseph, Louise Pilote, Kristian B. Filion · 2013 · Canadian Journal of Cardiology
150. Impairment of memory by fluoxetine in smokers.
     Richard A. Stein, Murray E. Jarvik, David A. Gorelick · 1993 · Experimental and Clinical Psychopharmacology
151. A comparative study of different modalities of treatment in nicotine dependence syndrome
     M. Chandrashekar, F.A. Sattar, Swapna Bondade, Kiran Kumar · 2015 · Asian Journal of Psychiatry
152. Perceived Treatment Assignment and Smoking Cessation in a Clinical Trial of Bupropion Versus Placebo
     T. S. Buchanan, L. Sanderson Cox, Janet Thomas, Nicole L. Nollen, Carla J. Berg, Matthew S. Mayo, Jasjit S. Ahluwalia · 2012 · Nicotine & Tobacco Research
153. Comparing the Tolerability and Effectiveness of Two Treatment Regimens in a Smoking Clinic
     Scott E. Sherman, Ileana Aldana, Maribel Estrada, Laura S. York · 2008 · Military Medicine
154. Assessment of depressive symptoms in severe smokers with minimal-mild depressive symptomatology receiving pre-smoking abstinence for integrated treatment: a randomized clinical trial
     Ana Beatriz Moreno-Coutiño, Facultad de Psicología, Universidad Nacional Autónoma de México, UNAM., Fabiola García-Anguiano, Silvia Ruiz‐Velasco, María Elena Medina‐Mora, Instituto de Investigaciones en Matemáticas Aplicadas y en Sistemas. Universidad Nacional Autónoma de México., Directora General del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. México. · 2015 · Salud Mental
155. Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study
     Yong Cui, Jeffrey M. Engelmann, Jonathan Z. Xian, Jennifer A. Minnix, Cho Y. Lam, Maher Karam‐Hage, Paul M. Cinciripini, Jason D. Robinson · 2017 · International Journal of Psychophysiology
156. Variants in the CHRNA5–CHRNA3–CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial
     Robert Culverhouse, Li-Shiun Chen, Nancy L. Saccone, Yinjiao Ma, Megan E. Piper, Timothy B Baker, Laura Jean Bierut · 2019 · Nicotine & Tobacco Research
157. Nicotine Reduction and Bupropion
     Joseph K. Neumann, Benjamin Peeples, Adam Seneker · 2002 · CHEST Journal
158. Effects of Depression History and Sex on the Efficacy of Sequential Versus Standard Fluoxetine for Smoking Cessation in Elevated Depressive Symptom Smokers
     Haruka Minami, Christopher W. Kahler, Erika Litvin Bloom, David R. Strong, Ana M. Abrantes, William H. Zywiak, Lawrence H. Price, Richard A. Brown · 2013 · Addictive Disorders & Their Treatment
159. Adherence to Pharmacological Smoking Cessation Treatment among Weight-Concerned Women
     Douglas A. Raynor · 2004 · D-Scholarship@Pitt (University of Pittsburgh)
160. Bupropion together with cognitive-conductual therapy (CBT) is an alternative for a long-term abstinence of smoking
     Eryka del Carmen Urdapilleta-Herrera, Mayra Fabiola Piña-Rosales, María Inés Vargas-Rojas, Alejandra Ramírez‐Venegas, Raúl H Sansores-Martínez · 2013 · European Respiratory Journal
161. The combination of sertraline with buspirone for smoking cessation process—The effectiveness and adverse events
     Daniela Ionescu, Carmen Cristescu · 2008 · Toxicology Letters
162. Bupropion assists with tobacco cessation in adolescents but relapse is high
     Dana Best · 2008 · The Journal of Pediatrics
163. High effectiveness of short treatment with bupropion for smoking cessation in general care
     Lutz Philipp Breitling, Dorothee Twardella, Hermann Brenner · 2008 · Thorax
164. Abstract P323: The Effect of Smoking Cessation on Weight at 12 Months in Patients Post-Myocardial Infarction
     Sonia Marzia Grandi, Kristian B. Filion, André Gervais, Lawrence Joseph, Jennifer L O’Loughlin, Gilles Paradis, Louise Pilote, Stéphane Rinfret, Mark Jeffrey Eisenberg · 2012 · Circulation
165. Baseline Predictors of Relapse to Smoking at 12 Months in Patients Post-Myocardial Infarction
     Sonia Marzia Grandi, Kristian B. Filion, Lee Joseph, Jennifer L O’Loughlin, Louise Pilote, Mark Jeffrey Eisenberg · 2013 · Canadian Journal of Cardiology
166. The efficacy of combination therapy with varenicline and bupropion for smoking cessation
     D.A. Johns · 2017 · Annals of Oncology
167. Perceived Treatment Assignment and Smoking Cessation in a Clinical Trial of Bupropion
     TS Buchanan, LS Cox, Nicole L. Nollen, J L Thomas, CJ Berg, MS Mayo, Jasjit S. Ahluwalia · 2011 · Cancer Epidemiology Biomarkers & Prevention
168. Risks and subjective effects of waterpipe versus cigarette smoking
     J Prignot · 2011 · Breathe
169. Predictors of retention in a multicomponent treatment for smokers
     Ana Beatriz Moreno-Coutiño, Alejandro Pérez-López, Luis Villalobos-Gallegos · 2016 · Archives of Clinical Psychiatry (São Paulo)
170. THE EFFECT OF ADHERENCE TO TREATMENT ON SMOKING ABSTINENCE IN PATIENTS POST-ACUTE MYOCARDIAL INFARCTION
     Sonia Marzia Grandi, Kristian B. Filion, André Gervais, Lawrence Joseph, Jennifer L O’Loughlin, Gilles Paradis, Louise Pilote, Stéphane Rinfret, Mark Jeffrey Eisenberg · 2012 · Journal of the American College of Cardiology
171. USE OF MEDICAL THERAPY IN PATIENTS 12 MONTHS POST-ACUTE MYOCARDIAL INFARCTION
     Sarah B. Windle, Sonia Marzia Grandi, Avi Shimony, André Gervais, Lawrence Joseph, Jennifer L O’Loughlin, Gilles Paradis, St eacute phane Rinfret, Louise Pilote, Mark Jeffrey Eisenberg · 2012 · Journal of the American College of Cardiology
172. Varenicline effective for smoking cessation.
     2006 · PubMed
173. Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting
     Porames Khunrong, Chanchai Sittipunt · 2016
174. Impairment of memory by fluoxetine in smokers.
     Richard A. Stein, Murray E. Jarvik, David A. Gorelick · 1993 · Experimental and Clinical Psychopharmacology
175. ФЕНОТИПИЧЕСКАЯ АДАПТАЦИЯ МОРСКИХ ЕЖЕЙ, ВЫРАЩЕННЫХ В УСЛОВИЯХ ОГРАНИЧЕННОГО ПРОСТРАНСТВА
     Р. Лиу, Ш. Педлар, А. Од · 2020 · Биофизика